Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 11/20 | 0.54 |
| ▸ | CNR2 | P34972 | 6/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.39 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.38 |
| ▸ | HPGDS | O60760 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3924944 | 0.92 | CNR1 (0.45) | CNR1CNR2SCN10AHPGDS | |
| SCHEMBL3812006 | 0.86 | CNR1 (0.49) | CNR1CNR2KCNH2SCN5ASCN2A | |
| SCHEMBL213232 | 0.85 | CNR1 (0.49) | CNR1CNR2KCNH2SCN5ASCN2A | |
| SCHEMBL4013402 | 0.84 | CNR1 (0.64) | CNR1CNR2KCNH2SCN5ASCN2A | |
| SCHEMBL4013626 | 0.83 | CNR1 (0.56) | CNR1CNR2 | |
| SCHEMBL4014812 | 0.83 | CNR1 (0.54) | CNR1CNR2 | |
| SCHEMBL4009905 | 0.83 | CNR1 (0.54) | CNR1CNR2 | |
| SCHEMBL4012883 | 0.83 | CNR1 (0.54) | CNR1CNR2 | |
| SCHEMBL3915821 | 0.83 | CNR1 (0.52) | CNR1CNR2 | |
| SCHEMBL3924890 | 0.83 | CNR1 (0.52) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074096-A1 | 3-PYRIDINECARBOXAMIDE AND 2-PYRAZINECARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | F.HOFFMANN-LA ROCHE AG (CH) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008040651-A1 | 3-PYRIDINECARBOXAMIDE AND 2-PYRAZINECARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-04-10 | — | — | WO | disclosed |